EFORT CONGRESS LISBON 2022 | EXHIBITORS & SPONSORS LIST

Nested Applications

LIS22 Past EFORT Congress Exhibitions

PAST EFORT CONGRESS EXHIBITIONS

EFORT understands that in order to assess the relevance of your company exhibiting during 23rd EFORT Congress Lisbon 2022 – it is often useful to see which companies have exhibited at previous EFORT congresses. For your convenience, therefore, please find the complete exhibitor listings for the following annual congresses via the links below:

For any enquiries relating to exhibition, satellites and sponsorship – please contact by using the official exhibitors and sponsorship contact us online form.

Note* : The global Covid-19 pandemic forced EFORT to take the difficult decision to postpone the 21st and 22nd EFORT Annual Congresses that was formerly planned to be held in Vienna, Austria in June 2020 and June-July 2021 respectively.

Exhibitors Database 2022

EXHIBITORS AND PARTNERS LISTING 2022

EFORT invites you to browse through the Exhibitors Database of the 23rd EFORT Annual Congress Lisbon 2022 which represents those exhibitors that have already committed to and confirmed their presence at the 2022 EFORT Congress to be held in Lisbon, Portugal from 22 to 24 June 2022.

EFORT Industry Database


Heraeus Medical GmbH

Philipp-Reis-Straße 8/13
61273 Wehrheim
Germany
Phone: +49 (0) 6181/35-3399
About Us

Heraeus Medical brings value to the patient, the healthcare professional and the health care system by providing solutions for the fixation of joint implants, driving infection management and by pioneering regenerative treatments for bone, cartilage and soft tissue. Treatments for muscoskeletal degeneration are highly specialized, costly and resources are restricted. Patients have to live with pain and loss of ability for long periods of time. Therefore Heraeus Medical has embraced this challenge and will develop effective, safe and affordable orthobiologic solutions.

Preventing infections from the outset - trust PALACOS®

PALACOS® bone cement is probably the best-known product from Heraeus and considered the Gold Standard for joint arthroplasty. For decades PALACOS® bone cement with Gentamicin allows for effective infection prophylaxis through local application of antibiotics. Recent data from the National Joint Registry (NJR) demonstrate that PALACOS® R+G has a significantly lower revision rate in comparison to all other cement brands in hip and knee replacements.

Prevention in Risk for Infection Procedures with COPAL® G+C

COPAL® G+C bone cement containing two antibiotics has long been used for revisions after replacement of hip or knee joints And now has proven that patients at risk of infection benefit from bone cement with a combination of antibiotics.

Heraeus with its extensive experience in the field of therapeutic support with local antibiotics, further provides high quality training and supports international knowledge projects on PJI.

PALAMIX – the next generation: Mixing and collecting under vacuum – now with spatula clip

The optimized PALAMIX® vacuum mixing system is the secret behind optimal processing of Heraeus bone cements.

It makes vacuum mixing and application of bone cement more convenient: both the mixing of the components and the collection of the bone cement is carried out under vacuum. A new spatula clip allows for the simple cement application in TKA.

Area of Business: Orthopaedic Industry
Category: Medical Devices
Number of Employees worldwide: 400+
Founded in: 2004
Products
PALACOS R+G
Bone cements were used in orthopaedics and trauma surgery since the 1950s. PMMA based bone cement is primarily used for mechanical anchorage of implants in bone. The addition of an antibiotic to the bone cement is a game changer in the fight against periprosthetic joint infections. PALACOS® R+G is produced at Heraeus Medical GmbH in Wehrheim, sold in more than 90 countries and used in more than 34 million procedures worldwide. The success of PALACOS® R+G is not only based on its unique polymer structure, which allows great antibiotic elution and thus leads to lower revision risks in knee and hip arthroplasty. Also, its mechanical properties lead to a stable fixation of the implant and increase the implant longevity in the bone. Let’s go back to 1969 where Prof. Dr. Buchholz, St George Hospital Hamburg, and Heraeus (Kulzer) GmbH were the first to consider adding an antibiotic to PMMA cement. The first results were encouraging – it seemed like the added antibiotic, Gentamicin, reduced the incidences of infections after arthroplasty. In order to minimize contamination during manual admixing of gentamicin powder to the PMMA cement, Prof. Buchholz and Heraeus started to develop the first industrially manufactured antibiotic loaded bone cement – in 1972 PALACOS® R+G was born. Today, 50 years after its invention, PALACOS® R+G became the gold standard. Although PALACOS® R+G offers a reliable product quality due to its unique structure, the real recipe of success lies in the people behind the product. We from Heraeus Medical want to say THANK YOU to everyone, who contributed to the success of PALACOS® R+G during the last 50 years.
Category: Antibiotic loaded bone cement